Results 21 to 30 of about 30,870 (207)

Telemedicine in pediatric rheumatology: this is the time for the community to embrace a new way of clinical practice

Pediatric Rheumatology Online Journal, 2020
Background The use of telemedicine in pediatric rheumatology has been historically low. The current COVID 19 global pandemic has forced a paradigm shift with many centers rapidly adopting virtual visits to conduct care resulting in rapid expansion of use
Susan Shenoi, Kristen Hayward, Megan L. Curran, Elizabeth Kessler, Jay J. Mehta, Meredith P. Riebschleger, Helen E. Foster   +6 more
doaj   +1 more source

Electronic health record modification and dashboard development to improve clinical care in pediatric rheumatology [PDF]

Frontiers in Pediatrics
Melissa Mannion
exaly   +2 more sources

The use of intravenous immunoglobulin in pediatric rheumatology

Rheumatology, 2014
Objectives : Intravenous immunoglobulin (IVIG) is applied in the treatment of primary immunodeficiency diseases, autoimmune disorders and inflammatory disorders.
Zbigniew Żuber, Marta Górnicka-Banach, Zofia Szymanowska, Dorota Turowska-Heydel, Małgorzata Sobczyk, Lidia Rutkowska-Sak   +5 more
doaj   +1 more source

Assessment of Resident Knowledge in Pediatric Rheumatology

Global Pediatric Health, 2021
Pediatric Rheumatic illnesses are complex, chronic, and often multi-systemic. Our goal was to assess the efficacy of 2 standardized pediatric rheumatology lectures, administered to pediatric residents, in improving the pediatric residents’ knowledge and ...
Tiffany Guglielmo-Roxby DO, Valerie Louissaint MD, Abigail Ettinger DO, Adana Llanos PhD, MPH, Ellen Cahill BA, Dalya Chefitz MD, Alexis Boneparth MD, Indira Amato MD, Lakshmi Nandini Moorthy MD, MPH   +8 more
doaj   +1 more source

Pediatric rheumatology: An under-recognized subspecialty in India

International Journal of Advanced Medical and Health Research, 2017
Pediatrics in India at the levels of both undergraduate and postgraduate training is often viewed upon as an acute disease specialty with little emphasis on chronic medical musculoskeletal diseases.
Akhila Kavirayani, Suma Balan
doaj   +1 more source

Practice Analysis and Determining the Knowledge and Skills Expected of a Pediatric Rheumatologist

ACR Open Rheumatology, 2023
Objective The scope of clinical practice of pediatric rheumatology has been difficult to define. The lack of definition prevents an accurate understanding of the knowledge and skills required of practicing pediatric rheumatologists.
Robert C. Brucia, Kristen Hayward, Hermine I. Brunner, Maricarmen Lopez‐Pena, Susan Shenoi, Arzu Soybilgic, James J. Nocton   +6 more
doaj   +1 more source

Paediatric rheumatology in Nigeria: history, challenges and the future

Frontiers in Pediatrics
Pediatric rheumatology is a relatively new subspecialty in Nigeria. For many years, rheumatic disease had not been well-recognized or studied in Nigeria, so there has been a low suspicion index.
Ayodele Faleye
doaj   +1 more source

Single Center Experience of Periodic Fever Syndromes

Çocuk Dergisi, 2022
Objective: We aimed to evaluate the patients referred to the pediatric rheumatology outpatient clinic with suspected periodic fever syndromes. Method: Patients diagnosed with periodic fever syndrome in the pediatric rheumatology outpatient clinic between
Şerife Gül Karadağ, Hafize Emine Sönmez, Ayşe Tanatar, Nuray Aktay Ayaz   +3 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source